| Literature DB >> 27545679 |
Tobias B Haack1, Erika Ignatius2, Javier Calvo-Garrido3, Arcangela Iuso4, Pirjo Isohanni2, Camilla Maffezzini5, Tuula Lönnqvist6, Anu Suomalainen7, Matteo Gorza8, Laura S Kremer4, Elisabeth Graf8, Monika Hartig9, Riccardo Berutti8, Martin Paucar10, Per Svenningsson10, Henrik Stranneheim11, Göran Brandberg12, Anna Wedell11, Manju A Kurian13, Susan A Hayflick14, Paola Venco15, Valeria Tiranti15, Tim M Strom4, Martin Dichgans16, Rita Horvath17, Elke Holinski-Feder18, Christoph Freyer19, Thomas Meitinger20, Holger Prokisch4, Jan Senderek21, Anna Wredenberg19, Christopher J Carroll7, Thomas Klopstock22.
Abstract
SQSTM1 (sequestosome 1; also known as p62) encodes a multidomain scaffolding protein involved in various key cellular processes, including the removal of damaged mitochondria by its function as a selective autophagy receptor. Heterozygous variants in SQSTM1 have been associated with Paget disease of the bone and might contribute to neurodegeneration in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Using exome sequencing, we identified three different biallelic loss-of-function variants in SQSTM1 in nine affected individuals from four families with a childhood- or adolescence-onset neurodegenerative disorder characterized by gait abnormalities, ataxia, dysarthria, dystonia, vertical gaze palsy, and cognitive decline. We confirmed absence of the SQSTM1/p62 protein in affected individuals' fibroblasts and found evidence of a defect in the early response to mitochondrial depolarization and autophagosome formation. Our findings expand the SQSTM1-associated phenotypic spectrum and lend further support to the concept of disturbed selective autophagy pathways in neurodegenerative diseases.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27545679 PMCID: PMC5010644 DOI: 10.1016/j.ajhg.2016.06.026
Source DB: PubMed Journal: Am J Hum Genet ISSN: 0002-9297 Impact factor: 11.025